JP2013544877A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544877A5
JP2013544877A5 JP2013542630A JP2013542630A JP2013544877A5 JP 2013544877 A5 JP2013544877 A5 JP 2013544877A5 JP 2013542630 A JP2013542630 A JP 2013542630A JP 2013542630 A JP2013542630 A JP 2013542630A JP 2013544877 A5 JP2013544877 A5 JP 2013544877A5
Authority
JP
Japan
Prior art keywords
compound
formula
thiadiazol
pyridin
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542630A
Other languages
English (en)
Japanese (ja)
Other versions
JP5851516B2 (ja
JP2013544877A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/050464 external-priority patent/WO2012076989A1/en
Publication of JP2013544877A publication Critical patent/JP2013544877A/ja
Publication of JP2013544877A5 publication Critical patent/JP2013544877A5/ja
Application granted granted Critical
Publication of JP5851516B2 publication Critical patent/JP5851516B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542630A 2010-12-09 2011-02-03 ケトライド化合物 Expired - Fee Related JP5851516B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3352/MUM/2010 2010-12-09
IN3352MU2010 2010-12-09
PCT/IB2011/050464 WO2012076989A1 (en) 2010-12-09 2011-02-03 Ketolide compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015135252A Division JP6102991B2 (ja) 2010-12-09 2015-07-06 ケトライド化合物

Publications (3)

Publication Number Publication Date
JP2013544877A JP2013544877A (ja) 2013-12-19
JP2013544877A5 true JP2013544877A5 (cg-RX-API-DMAC10.html) 2014-03-20
JP5851516B2 JP5851516B2 (ja) 2016-02-03

Family

ID=54259620

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013542630A Expired - Fee Related JP5851516B2 (ja) 2010-12-09 2011-02-03 ケトライド化合物
JP2015135252A Expired - Fee Related JP6102991B2 (ja) 2010-12-09 2015-07-06 ケトライド化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015135252A Expired - Fee Related JP6102991B2 (ja) 2010-12-09 2015-07-06 ケトライド化合物

Country Status (18)

Country Link
US (2) US9175031B2 (cg-RX-API-DMAC10.html)
EP (2) EP3216798A3 (cg-RX-API-DMAC10.html)
JP (2) JP5851516B2 (cg-RX-API-DMAC10.html)
KR (1) KR101657751B1 (cg-RX-API-DMAC10.html)
CN (2) CN103384676B (cg-RX-API-DMAC10.html)
AU (1) AU2011340204B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013014392B1 (cg-RX-API-DMAC10.html)
CA (2) CA2820451C (cg-RX-API-DMAC10.html)
DK (1) DK2673285T3 (cg-RX-API-DMAC10.html)
ES (1) ES2642287T3 (cg-RX-API-DMAC10.html)
HU (1) HUE036658T2 (cg-RX-API-DMAC10.html)
MX (1) MX348084B (cg-RX-API-DMAC10.html)
NZ (1) NZ623574A (cg-RX-API-DMAC10.html)
PL (1) PL2673285T3 (cg-RX-API-DMAC10.html)
PT (1) PT2673285T (cg-RX-API-DMAC10.html)
RU (1) RU2601550C2 (cg-RX-API-DMAC10.html)
WO (1) WO2012076989A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201304150B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ587490A (en) * 2010-08-20 2013-03-28 Greentide Ltd Anti-Microbial Compounds containing compounds with a sugar substituent
EP2688900B1 (en) * 2011-03-22 2016-09-28 Wockhardt Limited Process for preparation of ketolide compounds
US9346828B2 (en) 2013-06-07 2016-05-24 Wisconsin Alumni Research Foundation Forazolines, compositions thereof and uses thereof
NZ739211A (en) * 2015-07-27 2019-05-31 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same
BR112017027798B1 (pt) 2015-07-27 2023-12-19 Chong Kun Dang Pharmaceutical Corp Compostos de derivado de 1,3,4-oxadiazol sulfamida como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos
HRP20230052T1 (hr) 2015-07-27 2023-03-03 Chong Kun Dang Pharmaceutical Corp. Spojevi derivata 1,3,4-oksadiazol sulfonamida kao inhibitori histonske deacetilaze 6, i farmaceutski pripravak koji ih sadrži
HRP20220003T1 (hr) 2015-08-04 2022-04-01 Chong Kun Dang Pharmaceutical Corp. Spojevi derivata 1,3,4-oksadiazola kao inhibitori histonske deacetilaze 6, i farmaceutski pripravak koji ih sadrži
FI3362445T3 (fi) 2015-10-12 2023-03-21 Chong Kun Dang Pharmaceutical Corp Oksadiatsoliamiinijohdannaisyhdisteitä histonideasetylaasi 6:n inhibiittoreina ja niitä käsittävä farmaseuttinen koostumus
KR20180101509A (ko) * 2016-01-12 2018-09-12 욱크하르트 리미티드 약학 조성물
AU2017206671A1 (en) * 2016-01-12 2018-08-23 Wockhardt Limited Pharmaceutical compositions for the treatment of bacterial infections
WO2017122127A1 (en) * 2016-01-12 2017-07-20 Wockhardt Limited Pharmaceutical compositions
KR20190129863A (ko) * 2017-03-16 2019-11-20 욱크하르트 리미티드 케톨라이드 화합물의 제조 방법
KR102316234B1 (ko) 2018-07-26 2021-10-22 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
CN113874369B (zh) 2019-05-31 2024-08-27 株式会社钟根堂 作为组蛋白脱乙酰酶6抑制剂的1,3,4-噁二唑高邻苯二甲酰亚胺衍生化合物及包含其的药物组合物
US20230029266A1 (en) 2019-11-05 2023-01-26 Dermira, Inc. MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
AU2020380926B2 (en) * 2019-11-05 2026-07-16 Dermira, Inc. MrgprX2 antagonists and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DE69733439T2 (de) 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
JP2004514643A (ja) * 1997-10-29 2004-05-20 大正製薬株式会社 エリスロマイシンa誘導体
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
FR2777282B1 (fr) 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
MXPA03001607A (es) 2000-08-22 2003-06-04 Basilea Pharmaceutica Ag Nuevos macrolidos con actividad antibacteriana.
GB0031312D0 (en) 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
JP2004531471A (ja) * 2000-12-21 2004-10-14 グラクソ グループ リミテッド マクロライド抗生物質
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
CN101541331A (zh) * 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
MX2010002932A (es) * 2007-09-17 2010-05-27 Enanta Pharm Inc Macrolidos de biarilo con puente en 6, 11.
US8552162B2 (en) 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
EP2435460B1 (en) * 2009-05-27 2015-01-07 Wockhardt Limited Ketolide compounds having antimicrobial activity

Similar Documents

Publication Publication Date Title
RU2013131234A (ru) Кетолидные соединения
JP5728487B2 (ja) 三環式ヘテロ環化合物
US9255095B2 (en) Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
WO2017165256A1 (en) Allosteric modulators of nicotinic acetylcholine receptors
JP2014532626A5 (cg-RX-API-DMAC10.html)
UA122385C2 (uk) Сульфамоїлариламіди та їх застосування як лікарських препаратів для лікування гепатиту b
US20230382889A1 (en) Compounds for inhibiting kif18a
JP2010523643A5 (cg-RX-API-DMAC10.html)
EP1446403B1 (en) Aryl substituted oxazolidinones with antibacterial activity
JP2003515607A (ja) 置換イソオキサゾリン類及びその抗菌剤としての使用
JPWO2013018735A1 (ja) アミジン化合物又はその塩
CN102639513A (zh) 鞘氨醇激酶抑制剂
EP1437349A1 (en) Substituted isoxazoles and the use thereof as antibiotics
US20180127407A1 (en) Benzothiazole Or Benzoxazole Compounds As Sumo Activators
CN101142183A (zh) 有丝分裂驱动蛋白抑制剂
JP2017511368A5 (cg-RX-API-DMAC10.html)
EP3402785A1 (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
US7326790B2 (en) Diphenylisoxazole compounds and hydro isomers thereof
KR20040086465A (ko) 화합물
KR101169359B1 (ko) 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
RU2006140998A (ru) Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии
JP2017165653A (ja) アゾールカルボン酸誘導体
JP2014074018A5 (cg-RX-API-DMAC10.html)
JP2007517855A5 (cg-RX-API-DMAC10.html)
WO2010145203A1 (en) 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists